- call +1-201-465-4211
- email sales@mrinsights.biz
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Scope of the Report:
This report studies the Parkinson's Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parkinson's Disease Treatment market by product type and applications/end industries.
There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonistsbeing used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms.
The global Parkinson's Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parkinson's Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharmaceutical Industries
Wockhardt
Acadia Pharmaceuticals
UCB
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Market Segment by Applications, can be divided into
Hospitals
Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Parkinson's Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Treatment
1.2 Classification of Parkinson's Disease Treatment by Types
1.2.1 Global Parkinson's Disease Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Parkinson's Disease Treatment Revenue Market Share by Types in 2017
1.2.3 Levodopa/carbidopa
1.2.4 Dopamine Receptor Agonists
1.2.5 MAO-Inhibitors
1.2.6 COMT-inhibitors
1.2.7 Anticholinergics
1.3 Global Parkinson's Disease Treatment Market by Application
1.3.1 Global Parkinson's Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Parkinson's Disease Treatment Market by Regions
1.4.1 Global Parkinson's Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Parkinson's Disease Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Parkinson's Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Parkinson's Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Parkinson's Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva
2.4.1 Business Overview
2.4.2 Parkinson's Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Parkinson's Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Impax
2.6.1 Business Overview
2.6.2 Parkinson's Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Impax Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbvie
2.7.1 Business Overview
2.7.2 Parkinson's Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbvie Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bausch Health
2.8.1 Business Overview
2.8.2 Parkinson's Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bausch Health Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lundbeck
2.9.1 Business Overview
2.9.2 Parkinson's Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lundbeck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharmaceutical Industries
2.10.1 Business Overview
2.10.2 Parkinson's Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharmaceutical Industries Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Parkinson's Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Acadia Pharmaceuticals
2.12.1 Business Overview
2.12.2 Parkinson's Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Acadia Pharmaceuticals Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 UCB
2.13.1 Business Overview
2.13.2 Parkinson's Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 UCB Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parkinson's Disease Treatment Market Competition, by Players
3.1 Global Parkinson's Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson's Disease Treatment Players Market Share
3.2.2 Top 10 Parkinson's Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Parkinson's Disease Treatment Market Size by Regions
4.1 Global Parkinson's Disease Treatment Revenue and Market Share by Regions
4.2 North America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
5 North America Parkinson's Disease Treatment Revenue by Countries
5.1 North America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6 Europe Parkinson's Disease Treatment Revenue by Countries
6.1 Europe Parkinson's Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Parkinson's Disease Treatment Revenue by Countries
7.1 Asia-Pacific Parkinson's Disease Treatment Revenue by Countries (2013-2018)
7.2 China Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
8 South America Parkinson's Disease Treatment Revenue by Countries
8.1 South America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Parkinson's Disease Treatment by Countries
9.1 Middle East and Africa Parkinson's Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
10 Global Parkinson's Disease Treatment Market Segment by Type
10.1 Global Parkinson's Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Parkinson's Disease Treatment Market Forecast by Type (2018-2023)
10.3 Levodopa/carbidopa Revenue Growth Rate (2013-2023)
10.4 Dopamine Receptor Agonists Revenue Growth Rate (2013-2023)
10.5 MAO-Inhibitors Revenue Growth Rate (2013-2023)
10.6 COMT-inhibitors Revenue Growth Rate (2013-2023)
10.7 Anticholinergics Revenue Growth Rate (2013-2023)
11 Global Parkinson's Disease Treatment Market Segment by Application
11.1 Global Parkinson's Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Parkinson's Disease Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
12 Global Parkinson's Disease Treatment Market Size Forecast (2018-2023)
12.1 Global Parkinson's Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Parkinson's Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Parkinson's Disease Treatment Picture
Table Product Specifications of Parkinson's Disease Treatment
Table Global Parkinson's Disease Treatment and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
